Skip to main content
SpringerLink
Log in

Clinical Trials

  • Protocol
Vaccine Protocols

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 4))

Abstract

The transition from laboratory testing to evaluation in humans marks an important stage in vaccine development. Questions about safety and benefit to the patient and to the community may raise difficult ethical issues, whereas the inherent variability of human responses must be taken into account to obtain valid estimates of vaccine effect. This latter requirement explains why a coherent statistical framework for the design, analysis, and interpretation of clinical trials is regarded as essential today. A vast body of experience and methodology has been developed since the 1940s, when the scientific method was first applied systematically to the evaluation of vaccines. A striking feature of clinical trial research is its broad collaborative nature, involving laboratory, epidemiological, clinical, and statistical skills. As a consequence, rather than attempt to describe in detail the planning and conduct of clinical trials, this chapter will review the broad principles and stages involved in evaluating vaccines in humans, using examples from the literature. Details of methodological and other issues of particular relevance to vaccine evaluation are provided in Section 3.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Byar, D. P., Schoenfeld, D. A., Green, S. B., Amato, D. A., Davis, R., DeGruttda, V., et al. (1990) Design considerations for AIDS trials. N Engl. J. Med. 323, 1343–1348.

    Article  PubMed  CAS  Google Scholar 

  2. Bellanti, J. A., Zeligs, B. J., Vetro, S., Pung, Y.-H., Luccioli, S., Malvasic, M. J., Hook, A. M, Ubertini, T. R., Vanni, R., and Nencioni, L. (1993) Studies of safety, infectivity and immunogenicity of a new temperature-sensitive (ts) 51-1 strain of Salmonella typhi as a new live oral typhoid fever vaccine candidate. Vaccine 11, 587–590.

    Article  PubMed  CAS  Google Scholar 

  3. Costantino, P., Viti, S., Audino, P., Velmonte, M. A., Nencioni, L, and Rappuoli, R. (1992) Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine 10, 691–698.

    Article  PubMed  CAS  Google Scholar 

  4. Gold, R., Leplow, M. L., Goldchneider, I., Draper, T. F., and Gotschlich, E (1979) Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children J. Infect. Dis. 140, 690–697.

    PubMed  CAS  Google Scholar 

  5. Rutter, D. A., Ashworth, L. A. E., Day, A., Funnell, S., Lovell, F., and Robinson, A. (1988) Trial of a new acellular pertussis vaccine in healthy adult volunteers Vaccine 6, 29–32.

    Article  PubMed  CAS  Google Scholar 

  6. Bock, H L, Klockmann, U., Jungst, C., Schindel-Kunzel, F., Theobald, K., and Zerban, R. (1990) A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study. Vaccine 8, 22–24

    Article  PubMed  CAS  Google Scholar 

  7. Picard, O, Giral, P., Defer, M. C., Fouchard, M., Morel, M, Meyohas, M. C, et al. (1990) AIDS vaccine therapy: phase I trial (letter). Lancet 336, 179.

    Article  PubMed  CAS  Google Scholar 

  8. Scheifele, D., Bjornson, G., Barreto, L, Meekison, W., and Guasparini, R. (1992) Controlled trial of Haemophilus influenzae type B diphtheria toxoid conjugate combined with diphtheria, tetanus and pertussis vaccines, in 18-month old children, including comparison of arm versus thigh injection. Vaccine 10, 455–460.

    Article  PubMed  CAS  Google Scholar 

  9. Miller, E, Ashworth, L A., Robinson, A., Waight, P. A, and Irons, L. I. (1991) Phase II trial of whole-cell pertussis vaccine versus an acellular vaccine. Lancet 337, 70–73.

    Article  PubMed  CAS  Google Scholar 

  10. Pichichero, M. E., Marsocci, S. M., Francis, A B., Green, J. L., Disney, F A., Rennels, M. B., Lewis, E. D, Sugarman, L., Losonsky, G. A., Zito, E., and Davidson, B. L. (1993) A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants Vaccine 11, 747–753.

    Article  PubMed  CAS  Google Scholar 

  11. Strauss, S. E., Corey, L., Burke, R. L., Savarese, B., Barnum, G., Krause, P. R., Kost, R. G., Meir, J. L., Sekulovich, R., Adair, S. F., and Dekker, C. L. (1994) Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343, 1460–1463.

    Article  Google Scholar 

  12. Valero, M. V., Amador, L. R., Galindo, C., Figueroa, J., Bello, M. S., Murillo, L. A, et al (1993) Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 341, 705–710.

    Article  PubMed  CAS  Google Scholar 

  13. Sempertegui, F., Estrella B, Moscoso, J, Piedrahita, L, Hernandez, D., Gaybor, J., et al. (1994) Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador. Vaccine 12, 337–342.

    Article  PubMed  CAS  Google Scholar 

  14. Hall, A. J. and Aaby, P. (1990) Tropical trials and tribulations. Int. J. Epidemiol. 19, 777–781.

    Article  PubMed  CAS  Google Scholar 

  15. Francis, T, Korns, R. F., Voight, T., Boisen, M., Hemphill, F. M., Napier, J. A., and Tolchinsky, E. (1955) An evaluation of the 1954 poliomyelitis vaccine trials. Am J Public Health Part 2 45, 1–63.

    Google Scholar 

  16. Fine, P. E M. and Clarkson, J. A. (1987) Reflections on the efficacy of pertussis vaccines. Rev. Infect. Dis. 9, 866–883.

    Article  PubMed  CAS  Google Scholar 

  17. Vesikari, T. (1993) Clinical trials of live oral rotavirus vaccines: the Finnish experience. Vaccine 11, 255–261.

    Article  PubMed  CAS  Google Scholar 

  18. Medical Research Council (1951) The prevention of whooping-cough by vaccination: a Medical Research Council investigation. Br. Med. J. June 30, 1463–1471.

    Google Scholar 

  19. Farrington, C. P. (1990) Quantifying misclassification bias in cohort studies of vaccine efficacy. Stat Med. 9, 1327–1337.

    Article  PubMed  CAS  Google Scholar 

  20. PHLS Epidemiological Research Laboratory and 21 Area Health Authorities (1982) Efficacy of pertussis vaccination in England. Br. Med. J. 285, 357–359.

    Article  Google Scholar 

  21. Storsaeter, J., Hallander, H., Farrington, C. P., Olin, P., Mollby, R, and Miller, E. (1990) Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine 8, 457–461.

    Article  PubMed  CAS  Google Scholar 

  22. Ad-Hoc Group for the Study of Pertussis Vaccines (1988) Placebo-controlled trial of two acellular pertussis vaccines in Sweden: protective efficacy and adverse events. Lancet April 30, 955–960.

    Google Scholar 

  23. Volberding, P. A, Lagakos, S. W., Koch, M A., Pettinelli, C., Myers, M W., Booth, D. K., et al. (1990) Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N. Engl J. Med. 322, 941–949.

    Article  PubMed  CAS  Google Scholar 

  24. Simanjuntak, C. H., Paleologo, F., Punjabi, N. H., Darmowigoto, R., Soeprawoto, Totosuderjo, H., Haryanto, P., Suprijanto, E., Witham, N. D., and Hoffman, S. L. (1991) Oral immunisation against typhoid fever in Indonesia with Ty2la vaccine Lancet 338, 1055–1059.

    Article  PubMed  CAS  Google Scholar 

  25. Storsaeter, J., Olin, P., Renemar, B., Lagergard, T, Norberg, R., Romanus, V, Tiru, M., et al. (1988) Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden. Pediatr Infect. Dis. J. 7, 637–645

    Article  PubMed  CAS  Google Scholar 

  26. Garenne, M., Leroy, O., Beau, J.-P., and Sene, I. (1991) Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 338, 903–907.

    Article  PubMed  CAS  Google Scholar 

  27. Medical Research Council Whooping Cough Immunisation Committee (1956) Vaccination against whooping cough: relation between protection and results of laboratory tests Br. Med J. 2, 454–462.

    Article  Google Scholar 

  28. Orenstein, W. A., Bernier, R. H., Dondero, T. J., Hinman, A. R., Marks, J. S., Bart, K. J., and Sirotkin, B. (1985) Field evaluation of vaccine efficacy. WHO Bulletin 63, 1055–1068.

    CAS  Google Scholar 

  29. Begg, N. and Miller, E. (1990) Role of epidemiology in vaccine policy. Vaccine 8, 180–189.

    Article  PubMed  CAS  Google Scholar 

  30. PHLS Whooping-Cough Committee and Working Party (1973) Efficacy of whooping-cough vaccines used in the United Kingdom before 1968. Br. Med. J. Feb. 3, 259–262.

    Google Scholar 

  31. Miller, E., Goldacre, M., Pugh, S., Colville, A., Farrington, P., Flower, A., Nash, J., MacFarlane, L., and Tettmar, R. (1993) Risk of aseptic meningitis after measles mumps and rubella vaccine in UK children. Lancet 341, 979–982.

    Article  PubMed  CAS  Google Scholar 

  32. Farrington, P., Pugh, S., Colville, A., Flower, A., Nash, J., Morgan-Capner, P., et al. (1995) A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345, 567–569.

    Article  PubMed  CAS  Google Scholar 

  33. Diamond, A L and Laurence, D. R (1983) Compensation and drug trials (Commentary) Br Med. J. 287, 676–677.

    Article  Google Scholar 

  34. Association of the British Pharmaceutical Industry (1983) Compensation and drug trials. Br. Med. J. 287, 675.

    Article  Google Scholar 

  35. Pocock, S.J. (1983) Clinical Trials A Practical Approach. Wiley, Chichester.

    Google Scholar 

  36. Farrington, C. P. and Manning, G. (1990) Test statistics and sample size formulae for comparative binomial trials with null hypotheses of non-zero risk difference or non-unity relative risk. Stat. Med. 9, 1447–1454.

    Article  PubMed  CAS  Google Scholar 

  37. Machin, D. and Campbell, M. J. (1987) Statistical Tables for the Design of Clinical Trials Blackwell Scientific, Oxford.

    Google Scholar 

  38. Altman, D. G. and Dore, C. J. (1990) Randomisation and baselie comparisons in clinical trials. Lancet 335, 149–153.

    Article  PubMed  CAS  Google Scholar 

  39. Levine, M. M., Fereccio, C., Cryz, S., and Ortiz, E. (1990) Comparison of entericcoated capsules and liquid formulation of Ty2la typhoid vaccine in randomised controlled field trial. Lancet 336, 891–894.

    Article  PubMed  CAS  Google Scholar 

  40. Newell, D. J. (1992) Intention-to-treat analysis: implications for quantitative and qualitative research. Int. J. Epidemiol. 21, 837–841.

    Article  PubMed  CAS  Google Scholar 

  41. Farrington, C. P. (1993) Intention-to-treat analysis: implications for quantitative and qualitative research (letter). Int. J. Epidemiol. 22, 566.

    Article  PubMed  CAS  Google Scholar 

  42. Medical Research Council (1966) Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Br. Med. J. February 19, 441–446.

    Google Scholar 

  43. Clemens, J. D., Sack, D. A., Harris, J. R., Chakraborty, J., Khan, M. R., Stanton, B. F., Kay, B. A., Khan, M. U., Yunus, M., Atkinson, W., Svennerholm, A. M., and Holgren, J. (1986) Field trials of oral cholera vaccines in Bangladesh. Lancet July 19, 124–127.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Statistics Unit, PHLS Communicable Disease Surveillance Centre, London, UK

    Paddy Farrington & Elizabeth Miller

Authors
  1. Paddy Farrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Centre for Applied Microbiology and Research, Porton Down, UK

    Andrew Robinson , Graham H. Farrar  & Christopher N. Wiblin ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Humana Press Inc, Totowa, NJ

About this protocol

Cite this protocol

Farrington, P., Miller, E. (1996). Clinical Trials. In: Robinson, A., Farrar, G.H., Wiblin, C.N. (eds) Vaccine Protocols. Methods in Molecular Medicine™, vol 4. Humana Press. https://doi.org/10.1385/0-89603-334-1:251

Download citation

  • DOI: https://doi.org/10.1385/0-89603-334-1:251

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-334-4

  • Online ISBN: 978-1-59259-588-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation